Counteract Tablet
Product Images NDC 54473-166

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Counteract (NDC 54473-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Melaleuca, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Blister (Allergyblister)

CounterAct Allergy 10 mg Loratadine oral tablets in blister packaging. Each tablet is individually sealed with printed foil indicating the active ingredient, strength, and tablet count. Instructions to push the tablet through foil are shown. Distributed by Melaleuca, Inc., Idaho Falls, ID.*

FDA Label Image

Image Of Carton (Allergybox)

CounterAct Allergy Loratadine Tablets 10 mg oral tablet carton label with green background and blue text. Contains 30 tablets for indoor and outdoor allergy relief. Labeler is Melaleuca, Inc., showing Drug Facts panel including active ingredient, uses, warnings, directions, and inactive ingredients. Features claims of 24-hour relief from sneezing, runny nose, itchy watery eyes, and itchy throat or nose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.